Advancing and promoting knowledge of infections and vaccines


State-of-the-art techniques analysis for-omics research

Our research group uses the most modern genomic analysis techniques and state-of-the-art molecular and cell biology (omics technologies).

Through the combined analysis of genomes, transcriptomes, epigenomes, and integrative biology (cell culture, gene editing), GENVIP investigates the biological basis of infections using a novel host-based approach, and explores solutions for clinical practice.

GENVIP has set up a Clinical Trials Unit that is primarily focused on the field of vaccines. This unit channels most of the clinical trials conducted in Spain on pediatric vaccines, from Phase 1 to Phase 3. In addition, GENVIP partners with developers in the design of protocols and clinical development programs for a number of vaccine candidates.

GENVIP has established a series of national and international clinical networks of pediatric patients with infectious diseases. This enables the collection of a large amount of clinical data, as well as the creation of a large biobank, which are both key to the development of future scientific research.

GENVIP coordinates, among others, the Translational Research Network in Infectious Diseases [Red deInvestigación Traslacional en Enfermedades Infecciosas (RITIP)] and the Spanish Network of Pediatric ClinicalTrials [Red Española de Ensayos Clínicos Pediátricos (RECLIP)].


Our mission is to advance and promote knowledge on the genetic basis of pediatric infections and to contribute to the development of individualized strategies for their prevention and treatment.

Basic Research - Omics

Clinical Trials Unit

Professional unit
  • >100 Clinical Trials
  • >2500 Participants:
  • >10 Approved molecules
  • Collaborative platforms for maternal and adult immunization

Scientific communication and prod. - training

Impact factor > 4000 (JCR 2020)



Our facilities are distributed in different zones and buildings within the University Hospital of Santiago de Compostela

Management/Administrative and project management staff, Coordination are located on the first floor of the Hospital’s D Building, together with the Clinical Trials Unit, which is also in the first floor of the D building.

The laboratory area of GENVIP group, Laboratorio 19, is located in the facilities of the Health Research Institute of Santiago (IDIS) within the University Hospital Complex of Santiago de Compostela, which also houses other common work areas for IDIS researchers:

Research laboratories

Pre-PCR rooms

Post-PCR rooms

Culture rooms

Common equipment rooms andplatforms

IDIS currently houses more than 90 research groups with more than 1,000 researchers. Its infrastructure is designed to suit the flexibility, dynamism and interdisciplinary interactions of modern biomedical research, and promote synergies between the different research groups of the Institute.

GENVIP’s laboratory is equipped with state-of-the-art research technology in order to contribute to scientific knowledge, both in basic and clinical research, always from a translational perspective and placing the patient and their benefit at the center of our mission.

GENVIP's laboratory is equipped with the following technology:

Sequencer MinION+Flongle+Voltrax de Oxford Nanopore (NGS)

TapeStation 4200


PCR room

Fume Hood

Biosafety cabinet Class II A2

Basic laboratory equipment: stirrers, dry block heaters, vortex, centrifuges, slab heating ovens